Author

Yue Lin

Centre for Inflammation Research

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Adriano Giorgio RossiiD· 1 shared Amy LyiD· 1 shared Carsten Gram HanseniD· 1 shared Chandreyee DattaiD· 1 shared Chengjie HuangiD· 1 shared Ethan Plotsker· 1 shared Hongming CheniD· 1 shared J K CheniD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adriano Giorgio RossiORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A novel AR molecular glue degrader via bivalent engagement of the N-terminal domain and RNF213-UBE2J2 complex

Kunzhong Wu, Qiong Wu, Yongzhi Lu, Qi Yang, Ting Ran, Jie Zhang, Xianjie Qiu, Chengjie Huang, Yue Lin, J K Chen, Z L Yang, Wei Qin, Zhu Liu, Xinqi Liu, Miru Tang, , Jinsai Shang

This paper introduces GZL626, a novel AR degrader that targets the N-terminal domain and RNF213-UBE2J2 complex, effectively degrading AR and AR-V7 and showing antitumor and antiviral activity.

bioRxiv · Jul 16, 2026 · PreprintBiophysics

Development of a pipeline to evaluate YAP-TEAD inhibitor potential - direct TEAD inhibition represses cancerous growth in a NF2-mutant model of mesothelioma

Richard Cunningham, Siyang Jia, Krishna Pinganksha Purohit, Michaela Nosková, Marcin K Maniak, Yue Lin, Ning Sze Hui, Rebecca E. Graham, Adriano Giorgio Rossi, Justyna Cholewa-Waclaw, Pierre Bagnaninchi, Neil O. Carragher, Carsten Gram Hansen

The paper develops a pipeline to compare YAP/TAZ-TEAD inhibitors in mesothelioma models, identifying genetic compensation and off-target effects.

Life Science Alliance · Jul 31, 2025Peer-reviewedCancer Biology

Regulation of RNA methylation by therapy treatment, promotes tumor survival

Syed I. A. Bukhari, Samuel Spencer Truesdell, Chandreyee Datta, Pritha Choudhury, Keith Q. Wu, Jitendra Shrestha, Ruby Maharjan, Ethan Plotsker, Ramzi K. Elased, Sadia Laisa, Vijeta Bhambhani, Yue Lin, Johannes Kreuzer, Robert Tyler Morris, Siang‐Boon Koh, , Shobha Vasudevan

The paper shows that therapy-induced stress increases METTL3 translation, altering gene expression to promote tumor survival.

bioRxiv · May 19, 2023 · PreprintMolecular Biology